Black Americans are dying from COVID-19 at higher rates than others — but they are also getting vaccinated at lower rates

Washington, DC – Our nation has reached a grim milestone in the COVID-19 pandemic: over 400,000 Americans have died from complications of the coronavirus. Black Americans are 3.7 times as likely as white Americans to be hospitalized with COVID-19 and 2.8 times as likely to die.

Blacks and people of color are not inherently more susceptible to COVID-19 illness and mortality, however, existing structural racism contributes to the health disparities.

According to the Centers for Disease Control and Prevention, social determinants of health place many people of color at heightened risk for poor COVID-19 outcomes, including disparities in healthcare coverage and access; disproportionate representation in “essential” jobs that often carry greater virus-exposure risk; crowded housing conditions; and disparities in income, education and wealth.

Join/Renew/Refer a Friend to maximize the benefits of ABC membership!

MEMBERSHIP SPECIAL DISCOUNT OFFER

50% off 2021 membership dues! To take advantage of the discount offer today:

• Select membership type and enter discount code “thank you-50” in shopping cart;
• Special Discount Offer Deadline: February 26, 2021.

For questions, please contact Katrese Phelps McCullum at kphelps@abcardio.org.

This webinar will highlight the work of our COVID-19 Innovation Award Winners and COVID-19 Vaccine clinical challenges and opportunities in diverse and ethnic populations.

Structural Racism as a Public Health Crisis

Don Lloyd-Jones, MD, ScM, Michelle Albert, MD, MPH, and Lisa Cooper, MD, MPH discuss the impact of structural racism on public health, a crisis further aggravated as a result of the COVID-19 pandemic.

Solutions to Structural Racism

Michelle Albert, MD, MPH and Keith Churchwell, MD review some of the solutions discussed during Saturday’s session on Structural Racism as a Public Health Crisis and in the recent Presidential Advisory.

Details Forthcoming.

vent, a gathering of physicians, patient ad­vocates and corporate

vent, a gathering of physicians, patient ad­vocates and corporate

vent, a gathering of physicians, patient ad­vocates and corporate

vent, a gathering of physicians, patient ad­vocates and corporate

Our current webinar discussion is on Optimizing the Practice of Cardiovascular Medicine in the COVID-19 Era: Telehealth and More.  Watch this webinar and our previous webinars by clicking the button below.

At the click of a button you can participate in a live virtual event, a gathering of physicians, patient ad­vocates and

The ABC is proud to announce its partnership with HEARTLINE, a randomized, pragmatic, direct-to-participant digital trial sponsored by Johnson & Johnson in collaboration with Apple. The Heartline™ Study is a nationwide heart health research study designed to explore if the Heartline Study app on iPhone and heart health features on Apple Watch can enable earlier detection of an irregular heart rhythm known as atrial fibrillation (AFib), and potentially improve heart health outcomes, including reducing the risk of stroke.

If you’re 65 or older and interested in being a part of the study, visit Heartline.com to learn more and download the app to see if you’re eligible to enroll.

The coronavirus infection represents a global pandemic, that by definition, affects all populations. However, history has taught us that a differential impact often exists and is tightly linked to socio-demographic factors. There are a lot of questions about COVID-19, and the impact is evolving every day. Therefore, it is essential that we remain educated about ongoing events.

Stay informed with the latest science and clinical aspects of the coronavirus infection, and find helpful resources including frequently asked questions (FAQ) for health care providers, patients, and the public developed and curated by the ABC’s COVID-19 FAQ Watch editors and community programs committee.

The ABC Clinical Research Network (ABC CRN), provides investigators from multiple specialities with unparalleled access to clinical studies of interest while offering industry “one-stop” access to multiple investigators that ascribe to the same standard of clinical trial conduct.

Comprised of investigators from a variety of therapeutic areas, the ABC CRN was developed to serve as a central “wheel hub” to identify and vet clinical trial opportunities, match investigators to trials of inerest, and provide some of the infrastructure support that physicians say would be beneficial.